Response to: Correspondence on 'Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis' by Kountouras et al
- PMID: 35140107
- DOI: 10.1136/heartjnl-2022-320822
Response to: Correspondence on 'Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis' by Kountouras et al
Keywords: myocardial infarction; risk factors.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis.Heart. 2021 Jan;107(2):150-158. doi: 10.1136/heartjnl-2020-316780. Epub 2020 Aug 20. Heart. 2021. PMID: 32820013
-
Correspondence on 'Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis' by Rizos et al.Heart. 2022 Apr;108(8):657. doi: 10.1136/heartjnl-2020-318776. Epub 2022 Feb 9. Heart. 2022. PMID: 35140109 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources